Anti-Spike RBD Antibody (RP1-E4) is a monoclonal antibody that is specificly targeting for the spike receptor binding domain of SARS-CoV-2. It is useful tool to estimate the individual protection against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection. MW :80 KD.